Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2023 Feb 16;67(3):e00326-22. doi: 10.1128/aac.00326-22

Correction for Underwood et al., “Integrase Inhibitor Resistance Mechanisms and Structural Characteristics in Antiretroviral Therapy-Experienced, Integrase Inhibitor-Naive Adults with HIV-1 Infection Treated with Dolutegravir plus Two Nucleoside Reverse Transcriptase Inhibitors in the DAWNING Study”

Mark Underwood a,, Joe Horton b, Keith Nangle b, Judy Hopking c, Kimberly Smith a, Michael Aboud d, Brian Wynne a, Jörg Sievers d, Eugene L Stewart e, Ruolan Wang a
PMCID: PMC10019158  PMID: 36794938

AUTHOR CORRECTION

Volume 66, no. 1, e0164321, 2022, https://doi.org/10.1128/AAC.01643-21. Page 12, “Data availability” paragraph, line 2: The reported GenBank accession numbers (MZ568467 to MZ568625) are incorrect. The GenBank accession numbers should be MZ568548 to MZ568625.


Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES